RE: Charles Archer out with an article "Everything points to a sale"15 May 2026 06:54
I am well over half of my portfolio in here. Invested when it first came onto AIM and topped up a few times. Very high risk on reflection when you look at the early days, but my word I am confident of where this is heading :)
I sometimes wonder if I should sell on a peak like this, but it just feels different to other stocks. At any moment a massive RNS will move the SP beyond any opportunity to be able to get in cheap again.
Curious to see what the SP does on the MRE results, as I know the first time it wasn't well received by the market. Hopefully people's expectations are a little more reasonable and we over deliver. I mentioned it a few months back, but when you compared the XRF readings to the confirmed assay results in the first MRE the XRFs on average under-reported, so I have great confidence that what we already know is in the bag.
GLA